Synthetic biology funds back companies programming biology to create new materials, medicines, and chemicals. From engineered microbes to cell-free systems, these investors fuel the transition from petrochemical to biological manufacturing.
Showing 61-80 of 128 funds
Guatemala City, Guatemala
Auckland, New Zealand